Novartis at this time introduced a voluntary recall of three a number of Promacta (eltrombopag) 12.5 mg for oral suspension to the buyer degree. The oral suspension tons are being recalled due to a danger of potential peanut flour contamination that occurred at a third-party contract manufacturing website.
Source link
Related Posts
Add A Comment